查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1828149

2025年神经调节全球市场报告

Neuromodulation Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，神经调节市场规模强劲成长，从2024年的69.6亿美元增加至2025年的76.2亿美元，复合年增长率达9.5%。预测期内的增长可归因于慢性病患病率的上升、临床证据和研究、患者对非侵入性治疗的需求、政府倡议和资金投入、适应症的扩大、合作研究以及伙伴关係的建立。

预计未来几年神经调节市场规模将快速成长，到2029年将达到115.7亿美元，复合年增长率为11.0%。预测期内的成长可归因于设备小型化、老龄化社会对神经系统疾病的关注度增加、精神病学应用的扩展、以患者为中心的治疗方法以及全球医疗保健可及性的提高。预测期内的主要趋势包括人工智慧 (AI) 的整合、技术进步、非侵入性神经调节技术、闭合迴路神经调节系统、适应症的扩展以及无线和穿戴式神经调节设备。

神经调节是指透过电刺激或药理方法直接针对特定的神经活动。它是一种缓解疼痛的可逆方法。

神经调节技术主要分为体内和体外两种。体内神经调节是指在目标神经附近植入电极并传送低压电流。生物材料包括聚合物、金属和陶瓷材料。这些技术用于治疗多种疾病，包括慢性疼痛、尿失禁和大便失禁、偏头痛、下背痛、帕金森氏症、癫痫、震颤和忧郁症。它们在医院、诊所和家庭医疗保健等各种环境中都有应用。

2025年春季，美国关税上调及其引发的贸易摩擦对医疗设备产业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要重新认证医疗设备，导致市场准入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供神经调节市场统计数据，例如全球市场规模、区域份额、神经调节市场份额的竞争对手、详细的神经调节细分市场、市场趋势以及神经调节行业的商机，为您提供在神经调节行业取得成功所需的数据。本神经调节市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供全面的观点，满足您的所有需求。

未来五年11.0%的成长率预测，较我们先前对该市场的预测略有下降0.3%。这一下降主要源自于美国与其他国家之间关税的影响。由于互惠关税以及日益加剧的贸易紧张局势和限制对全球经济和贸易的负面影响，其影响将更加广泛。

神经系统疾病的日益普及是推动神经调节市场成长的关键因素。这些疾病包括影响大脑、神经和脊髓的各种问题。神经调节干预为管理和调节各种神经系统疾病（包括阿兹海默症、帕金森氏症和癫痫）提供了一种有前途的方法。欧洲脑理事会于 2022 年 4 月发布的一份报告显示，全球整体有 600 多种神经系统疾病和近 300 种精神疾病，5,000 万人患有阿兹海默症和其他失智症。癫痫影响全球 6500 万人，凸显了神经系统疾病的重大影响。预计到 2050 年，欧洲失智症患者的数量将从 1,050 万大幅增加到 1,870 万，这意味着神经调节将在解决这一日益严重的健康问题中发挥关键作用。

预计未来几年，不断增长的医疗保健支出将推动神经调节市场的成长。医疗保健支出包括分配给医疗保健及相关活动（例如医疗服务提供、公共和私人医疗保险、健康研究以及公共卫生活动）的总资金。不断增长的支出将支持神经系统疾病新治疗方法和诊断方法的开发和应用，并为创新神经调节技术的研发、疗效、安全性和标靶性提供额外资金。例如，2022年11月，总部位于美国的非营利组织加拿大卫生资讯研究所报告称，2022年医疗保健支出将增加0.8%，达到3,310亿美元，而2021年的增幅为7.6%。因此，不断增长的医疗保健支出正在推动神经调节市场的成长。

技术进步是推动神经调节市场发展的关键趋势。该领域的主要企业正致力于开发创新的技术解决方案，以提升其市场地位。例如，2024 年 1 月，专注于数位自我神经调节疗法的以色列公司 GrayMatters Health 宣布推出 Prism，这是一种经 FDA 批准的用于治疗创伤后压力症候群 (PTSD) 的新型自我神经调节疗法。这款尖端设备整合了脑电图帽和软体，可帮助患者透过神经回馈管理情绪反应。该技术旨在透过为患者提供主动管理症状的工具来补充传统的心理治疗和药物治疗。此外，2022 年 12 月，美国医疗设备和医疗保健公司雅培实验室宣布推出 Eterna 脊髓刺激 (SCS) 系统，这是目前最小的可植入、可充电脊髓刺激设备。 Eterna SCS 采用雅培专利的低剂量 BurstDR 刺激技术，是唯一获得最高等级临床证据（1A 证据）支持的 SCS 波形创新技术，与传统波形技术相比，疼痛缓解效果提高了 23%。

主要企业正专注于推出具有先进功能的下一代设备，例如植入式脉衝产生器 (IPG)，以获得竞争优势。 Barostim Neo2 IPG 就是其中一个例子，它是 CVRx 用于治疗心臟衰竭领域对患者友好、耐用且高效的解决方案的追求。

2022年3月，美国知名医疗设备製造商ElectroMedical Products International, Inc. (EPI) 收购了Pulvinar Neuro LLC，具体金额未揭露。此次策略性收购使EPI能够进一步推进其取得专利的技术，尤其是经颅交流电刺激(tACS)、增强型个人化回馈刺激以及扩展的云端数位疗法，用于治疗精神和神经系统疾病。 Pulvinar Neuro是一家总部位于美国的神经科技公司，专注于利用最尖端科技支持神经科学研究，与EPI推动该领域医疗创新的目标完美契合。

神经调节市场的主要企业包括雅培实验室、Soterix Medical Inc.、波士顿科学公司、美敦力公司、Synapse Biomedical Inc.、Nevro Corp、Neuropace Inc.、LivaNova PLC、Neurosigma Inc.、Neuronetics Inc.、Bioness Inc.、Aleva Neurooxyutics SASmerat Corporation. Ltd、Otolith Labs Inc.、Machine Medicine Inc.、Inbrain Neuroelectronics SAS、Pixium Vision SA、Neuromod Devices Limited、Cognito Therapeutics Inc.、PathMaker Neurosystems Inc.、Dignify Therapeutics Inc. , Omron Corporation。

2024年神经调节市场最大的地区是北美。神经调节市场报告涵盖的地区包括亚太地区、西欧、东欧、北美、南美、中东和非洲。

神经调节市场报告涵盖的国家有澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国、美国、加拿大、义大利、西班牙

神经调节市场涵盖营业单位透过治疗骨盆腔疾病和失禁的荐椎神经刺激、治疗巴金森氏症的深部脑刺激 (DBS) 以及治疗缺血性疾病（心绞痛、週边血管疾病）的脊髓刺激产生的收益。市场价值包括服务提供者销售或包含在服务产品中的相关商品的价值。仅包括企业之间交易或销售给最终消费者的商品和服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球神经调节：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球神经调节市场：成长率分析
  • 全球神经调节市场表现：规模与成长，2019-2024
  • 全球神经调节市场预测：规模与成长，2024-2029，2034
  • 全球神经调节：总目标市场（TAM）

第六章 市场细分

  • 全球神经调节市场（按技术、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 内部神经调节
  • 外部神经调节（非侵入性）
  • 全球神经调节市场（按生医材料、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 聚合物生医材料
  • 金属生医材料
  • 陶瓷生医材料
  • 全球神经调节市场的应用、表现和预测，2019-2024 年、2024-2029 年、2034 年
  • 慢性疼痛
  • 尿失禁/大便失禁
  • 偏头痛
  • 故障恢復综合症
  • 帕金森氏症
  • 癫痫
  • 震颤
  • 忧郁症
  • 其他用途
  • 全球神经调节市场（按最终用户、绩效和预测），2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 诊所
  • 家庭医疗保健
  • 全球神经调节市场：按内部神经调节细分，按类型、表现和预测，2019-2024 年、2024-2029 年、2034 年
  • 植入式装置
  • 椎管内药物输送系统
  • 全球神经调节市场：按外部神经调节（非侵入性）细分，类型，表现和预测，2019-2024 年、2024-2029 年、2034 年
  • 经颅磁刺激（TMS）
  • 经颅直流电刺激（tDCS）
  • 经皮电刺激（TENS）
  • 週边神经刺激（PNS）

第七章 区域和国家分析

  • 全球神经调节市场：按地区、绩效和预测，2019-2024 年、2024-2029 年、2034 年
  • 全球神经调节市场：依国家、表现及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 神经调节市场：竞争格局
  • 神经调节市场：公司简介
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Soterix Medical Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • Synapse Biomedical Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Nevro Corp
  • Neuropace Inc.
  • LivaNova PLC
  • Neurosigma Inc.
  • Neuronetics Inc.
  • Bioness Inc.
  • Aleva Neurotherapeutics SA
  • Integer Holdings Corporation
  • ReShape Lifesciences Inc.
  • Inspire Medical Systems Inc.
  • Bioventus LLC
  • Saluda Medical Pty Ltd
  • Otolith Labs Inc.
  • Machine Medicine Inc.
  • Inbrain Neuroelectronics SAS

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029 神经调节市场：提供新机会的国家
  • 2029 神经调节市场：细分领域带来新机会
  • 2029 神经调节市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r24363u

Neuromodulation refers to the adjustment of nerve activity through electrical or pharmacological means, directly targeting specific areas. It's a reversible method employed to alleviate pain.

The primary technologies in neuromodulation include internal and external methods. Internal neuromodulation involves implanting an electrode near a targeted nerve and administering a low-voltage electric current. Biomaterials used encompass polymeric, metallic, and ceramic materials. These technologies are applied in treating various conditions such as chronic pain, urinary and fecal incontinence, migraine, failed back syndrome, Parkinson's disease, epilepsy, tremor, depression, and more. They find use across multiple settings including hospitals, clinics, and home healthcare environments.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The neuromodulation market research report is one of a series of new reports from The Business Research Company that provides neuromodulation market statistics, including the neuromodulation industry's global market size, regional shares, competitors with a neuromodulation market share, detailed neuromodulation market segments, market trends, and opportunities, and any further data you may need to thrive in the neuromodulation industry. This neuromodulation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The neuromodulation market size has grown strongly in recent years. It will grow from $6.96 billion in 2024 to $7.62 billion in 2025 at a compound annual growth rate (CAGR) of 9.5%. The growth in the historic period can be attributed to rising prevalence of chronic disorders, clinical evidence and research, patient demand for non-invasive therapies, government initiatives and funding, expansion of indications, collaborations and partnerships.

The neuromodulation market size is expected to see rapid growth in the next few years. It will grow to $11.57 billion in 2029 at a compound annual growth rate (CAGR) of 11.0%. The growth in the forecast period can be attributed to miniaturization of devices, focus on neurological disorders in aging population, expanded applications in psychiatry, patient-centric approaches, global expansion of healthcare access. Major trends in the forecast period include integration of artificial intelligence (ai), advancements in technology, non-invasive neuromodulation techniques, closed-loop neuromodulation systems, expansion of indications, wireless and wearable neuromodulation devices.

The forecast of 11.0% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through increased duties on rechargeable battery systems from China, raising costs for spinal cord stimulators and affecting chronic pain management treatment options.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of neurological disorders stands as a significant driver for the growth of the neuromodulation market. These disorders encompass a wide range of issues affecting the brain, nerves, and spinal cord. Neuromodulation interventions offer promising avenues for managing and regulating various neurological conditions, including Alzheimer's, Parkinson's, and epilepsy. Reports from the European Brain Council in April 2022 highlighted over 600 neurological diseases and nearly 300 psychiatric conditions globally, with 50 million individuals affected by Alzheimer's and other dementias. Epilepsy, affecting 65 million people worldwide, underscores the substantial impact of neurological disorders. Projections indicate a substantial rise in dementia cases in Europe, from 10.5 million to 18.7 million by 2050, signifying the pivotal role of neuromodulation in addressing these escalating health concerns.

Increasing healthcare expenditures are projected to drive the growth of the neuromodulation market in the coming years. Healthcare expenditure encompasses the total funds allocated for health care and related activities, including health services provision, public and private health insurance, health research, and public health initiatives. Rising expenditures support the development and adoption of new therapies and diagnostic methods for neurological disorders, and they also provide additional funding for research into innovative neuromodulation technologies, enhancing their efficacy, safety, and targeting capabilities. For example, in November 2022, the Canadian Institute for Health Information, a not-for-profit organization based in the U.S., reported that healthcare expenditure increased by 0.8% to reach $331 billion in 2022, compared to 7.6% in 2021. Thus, the rising healthcare expenditure is fueling the growth of the neuromodulation market.

Technological advancements are a significant trend gaining traction in the neuromodulation market. Leading companies in this sector are concentrating on developing innovative technological solutions to enhance their market position. For instance, in January 2024, GrayMatters Health, an Israel-based firm focused on digital self-neuromodulation therapies, introduced a new FDA-cleared self-neuromodulation therapy for PTSD called Prism. This cutting-edge device integrates an EEG cap with software to assist patients in learning to manage their emotional responses through neurofeedback. The technology aims to complement traditional psychotherapy and pharmacotherapy by equipping patients with tools to actively manage their symptoms. Additionally, in December 2022, Abbott Laboratories, a U.S.-based medical devices and healthcare company, unveiled the Eterna spinal cord stimulation (SCS) system, which is the smallest implantable, rechargeable spinal cord stimulator available. Eterna SCS utilizes Abbott's patented low-dose BurstDR stimulation, the only SCS waveform innovation backed by the highest level of clinical evidence (1A evidence), demonstrating a 23% greater pain relief compared to conventional waveform technology.

Major players in the neuromodulation market are focusing on introducing next-generation devices with advanced features, such as the implantable pulse generator (IPG), to gain a competitive edge. For example, CVRx's November 2022 launch of the Barostim Neo2 IPG, an upgraded version of its neuromodulation device for heart failure treatment, exemplifies this pursuit. With improved efficiency, reduced size, and enhanced design facilitating easier implantation, the Barostim Neo2 retains the clinically proven Barostim therapy, emphasizing the drive towards patient-friendly, durable, and efficient solutions in neuromodulation.

In March 2022, Electromedical Products International Inc (EPI), a prominent US-based medical device manufacturer, completed the acquisition of Pulvinar Neuro LLC for an undisclosed sum. This strategic acquisition empowers EPI to further its progress in advancing patented technologies, notably transcranial alternating current stimulation (tACS), enhancing personalized feedback stimulation, and expanding its cloud-enabled digital therapeutics for psychiatric and neurological conditions. Pulvinar Neuro, a US-based neurotechnology company, specializes in leveraging cutting-edge technologies to support neuroscience research, aligning seamlessly with EPI's objectives in advancing medical innovation in this domain.

Major companies operating in the neuromodulation market include Abbott Laboratories, Soterix Medical Inc., Boston Scientific Corporation, Medtronic plc, Synapse Biomedical Inc., Nevro Corp, Neuropace Inc., LivaNova PLC, Neurosigma Inc., Neuronetics Inc., Bioness Inc., Aleva Neurotherapeutics S.A., Integer Holdings Corporation, ReShape Lifesciences Inc., Inspire Medical Systems Inc., Bioventus LLC, Saluda Medical Pty Ltd, Otolith Labs Inc., Machine Medicine Inc., Inbrain Neuroelectronics SAS, Pixium Vision SA, Neuromod Devices Limited, Cognito Therapeutics Inc., PathMaker Neurosystems Inc., Dignify Therapeutics Inc., Neuronoff ApS, Neuros Medical Inc., Fisher & Paykel Healthcare Corporation Limited, Koninklijke Philips N.V., Magic Leap Inc., Omron Corporation

North America was the largest region in the neuromodulation market in 2024. The regions covered in the neuromodulation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the neuromodulation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The neuromodulation market includes revenues earned by entities through sacral nerve stimulation for pelvic disorders and incontinence, deep brain stimulation (DBS) treatment for Parkinson's disease, and spinal cord stimulation for ischemic disorders (angina, peripheral vascular disease). The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Neuromodulation Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on neuromodulation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for neuromodulation ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The neuromodulation market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Technology: Internal Neuromodulation; External Neuromodulation (Non-invasive)
  • 2) By Biomaterial: Polymeric Biomaterial; Metallic Biomaterial; Ceramic Biomaterial
  • 3) By Application: Chronic Pain; Urinary And Fecal Incontinence; Migraine; Failed Back Syndrome; Parkinson Disease; Epilepsy; Tremor; Depression; Other Applications
  • 4) By End-User: Hospitals; Clinics; Home Healthcare
  • Subsegments:
  • 1) By Internal Neuromodulation: Implantable Devices; Intrathecal Drug Delivery Systems
  • 2) By External Neuromodulation (Non-invasive): Transcranial Magnetic Stimulation (TMS); Transcranial Direct Current Stimulation (tDCS); Transcutaneous Electrical Nerve Stimulation (TENS); Peripheral Nerve Stimulation (PNS)
  • Companies Mentioned: Abbott Laboratories; Soterix Medical Inc.; Boston Scientific Corporation; Medtronic plc; Synapse Biomedical Inc.; Nevro Corp; Neuropace Inc.; LivaNova PLC; Neurosigma Inc.; Neuronetics Inc.; Bioness Inc.; Aleva Neurotherapeutics S.A.; Integer Holdings Corporation; ReShape Lifesciences Inc.; Inspire Medical Systems Inc.; Bioventus LLC; Saluda Medical Pty Ltd; Otolith Labs Inc.; Machine Medicine Inc.; Inbrain Neuroelectronics SAS; Pixium Vision SA; Neuromod Devices Limited; Cognito Therapeutics Inc.; PathMaker Neurosystems Inc.; Dignify Therapeutics Inc.; Neuronoff ApS; Neuros Medical Inc.; Fisher & Paykel Healthcare Corporation Limited; Koninklijke Philips N.V.; Magic Leap Inc.; Omron Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Neuromodulation Market Characteristics

3. Neuromodulation Market Trends And Strategies

4. Neuromodulation Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Neuromodulation Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Neuromodulation PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Neuromodulation Market Growth Rate Analysis
  • 5.4. Global Neuromodulation Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Neuromodulation Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Neuromodulation Total Addressable Market (TAM)

6. Neuromodulation Market Segmentation

  • 6.1. Global Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Internal Neuromodulation
  • External Neuromodulation (Non-invasive)
  • 6.2. Global Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Polymeric Biomaterial
  • Metallic Biomaterial
  • Ceramic Biomaterial
  • 6.3. Global Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Chronic Pain
  • Urinary And Fecal Incontinence
  • Migraine
  • Failed Back Syndrome
  • Parkinson Disease
  • Epilepsy
  • Tremor
  • Depression
  • Other Applications
  • 6.4. Global Neuromodulation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Clinics
  • Home Healthcare
  • 6.5. Global Neuromodulation Market, Sub-Segmentation Of Internal Neuromodulation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Implantable Devices
  • Intrathecal Drug Delivery Systems
  • 6.6. Global Neuromodulation Market, Sub-Segmentation Of External Neuromodulation (Non-invasive), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Transcranial Magnetic Stimulation (TMS)
  • Transcranial Direct Current Stimulation (tDCS)
  • Transcutaneous Electrical Nerve Stimulation (TENS)
  • Peripheral Nerve Stimulation (PNS)

7. Neuromodulation Market Regional And Country Analysis

  • 7.1. Global Neuromodulation Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Neuromodulation Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Neuromodulation Market

  • 8.1. Asia-Pacific Neuromodulation Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Neuromodulation Market

  • 9.1. China Neuromodulation Market Overview
  • 9.2. China Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Neuromodulation Market

  • 10.1. India Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Neuromodulation Market

  • 11.1. Japan Neuromodulation Market Overview
  • 11.2. Japan Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Neuromodulation Market

  • 12.1. Australia Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Neuromodulation Market

  • 13.1. Indonesia Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Neuromodulation Market

  • 14.1. South Korea Neuromodulation Market Overview
  • 14.2. South Korea Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Neuromodulation Market

  • 15.1. Western Europe Neuromodulation Market Overview
  • 15.2. Western Europe Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Neuromodulation Market

  • 16.1. UK Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Neuromodulation Market

  • 17.1. Germany Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Neuromodulation Market

  • 18.1. France Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Neuromodulation Market

  • 19.1. Italy Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Neuromodulation Market

  • 20.1. Spain Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Neuromodulation Market

  • 21.1. Eastern Europe Neuromodulation Market Overview
  • 21.2. Eastern Europe Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Neuromodulation Market

  • 22.1. Russia Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Neuromodulation Market

  • 23.1. North America Neuromodulation Market Overview
  • 23.2. North America Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Neuromodulation Market

  • 24.1. USA Neuromodulation Market Overview
  • 24.2. USA Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Neuromodulation Market

  • 25.1. Canada Neuromodulation Market Overview
  • 25.2. Canada Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Neuromodulation Market

  • 26.1. South America Neuromodulation Market Overview
  • 26.2. South America Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Neuromodulation Market

  • 27.1. Brazil Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Neuromodulation Market

  • 28.1. Middle East Neuromodulation Market Overview
  • 28.2. Middle East Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Neuromodulation Market

  • 29.1. Africa Neuromodulation Market Overview
  • 29.2. Africa Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Neuromodulation Market Competitive Landscape And Company Profiles

  • 30.1. Neuromodulation Market Competitive Landscape
  • 30.2. Neuromodulation Market Company Profiles
    • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Soterix Medical Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Synapse Biomedical Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Neuromodulation Market Other Major And Innovative Companies

  • 31.1. Nevro Corp
  • 31.2. Neuropace Inc.
  • 31.3. LivaNova PLC
  • 31.4. Neurosigma Inc.
  • 31.5. Neuronetics Inc.
  • 31.6. Bioness Inc.
  • 31.7. Aleva Neurotherapeutics S.A.
  • 31.8. Integer Holdings Corporation
  • 31.9. ReShape Lifesciences Inc.
  • 31.10. Inspire Medical Systems Inc.
  • 31.11. Bioventus LLC
  • 31.12. Saluda Medical Pty Ltd
  • 31.13. Otolith Labs Inc.
  • 31.14. Machine Medicine Inc.
  • 31.15. Inbrain Neuroelectronics SAS

32. Global Neuromodulation Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Neuromodulation Market

34. Recent Developments In The Neuromodulation Market

35. Neuromodulation Market High Potential Countries, Segments and Strategies

  • 35.1 Neuromodulation Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Neuromodulation Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Neuromodulation Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer